Virus Receptors: Implications for Pathogenesis and the Design of Antiviral Agents

Overview

Journal Clin Microbiol Rev

Publisher American Society for Microbiology

Specialty Microbiology

Date 1995 Apr 1

PMID 7621403

Citations 22

Authors

L C Norkin

Affiliations

Soon will be listed here.

Abstract

A virus initiates infection by attaching to its specific receptor on the surface of a susceptible host cell. This prepares the way for the virus to enter the cell. Consequently, the expression of the receptor on specific cells and tissues of the host is a major determinant of the route of entry of the virus into the host and of the patterns of virus spread and pathogenesis in the host. This review emphasizes the virus-receptor interactions of human immunodeficiency virus, the rhinoviruses, the herpesviruses, and the coronaviruses. These interactions are often found to be complex and dynamic, involving multiple sites or factors on both the virus and the host cell. Also, the receptor may play an important role in virus entry per se in addition to its role in virus binding. In the cases of human immunodeficiency virus and the rhinoviruses, ingenious approaches to therapeutic strategies based on inhibiting virus attachment and entry are under development and in clinical trials.

Citing Articles

Quaternized Chitosan Derivatives as Viable Antiviral Agents: Structure-Activity Correlations and Mechanisms of Action.

Teotia A, Lauren I, Borandeh S, Seppala J ACS Appl Mater Interfaces. 2023; 15(15):18707-18719.

PMID: 37014147 PMC: 10119858. DOI: 10.1021/acsami.3c01421.

Seven classes of antiviral agents.

Ianevski A, Ahmad S, Anunnitipat K, Oksenych V, Zusinaite E, Tenson T Cell Mol Life Sci. 2022; 79(12):605.

PMID: 36436108 PMC: 9701656. DOI: 10.1007/s00018-022-04635-1.

Hold Breath: Autonomic Neural Regulation of Innate Immunity to Defend Against SARS-CoV-2 Infection.

Wang C, Zhao Y, Qiao H, Gao Z, Yang J, Chuai X Front Microbiol. 2022; 12:819638.

PMID: 35310398 PMC: 8929440. DOI: 10.3389/fmicb.2021.819638.

Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis.

Bhowmik D, Nandi R, Prakash A, Kumar D Heliyon. 2021; 7(3):e06515.

PMID: 33748510 PMC: 7955945. DOI: 10.1016/j.heliyon.2021.e06515.

Coronavirus Disease 2019-COVID-19.

Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Singh Malik Y Clin Microbiol Rev. 2020; 33(4).

PMID: 32580969 PMC: 7405836. DOI: 10.1128/CMR.00028-20.

References

Mirda D, Navarro D, Paz P, Lee P, Pereira L, Williams L . The fibroblast growth factor receptor is not required for herpes simplex virus type 1 infection. J Virol. 1992; 66(1):448-57. PMC: 238305. DOI: 10.1128/JVI.66.1.448-457.1992. View

Page K, Stearns S, Littman D . Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity. J Virol. 1992; 66(1):524-33. PMC: 238313. DOI: 10.1128/JVI.66.1.524-533.1992. View

Fantini J, Yahi N, Baghdiguian S, Chermann J . Human colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion. J Virol. 1992; 66(1):580-5. PMC: 238320. DOI: 10.1128/JVI.66.1.580-585.1992. View

Travis B, Dykers T, Hewgill D, Ledbetter J, Tsu T, Hu S . Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells. Virology. 1992; 186(1):313-7. DOI: 10.1016/0042-6822(92)90088-7. View

Takeuchi Y, Vile R, Simpson G, OHara B, Collins M, Weiss R . Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J Virol. 1992; 66(2):1219-22. PMC: 240831. DOI: 10.1128/JVI.66.2.1219-1222.1992. View

Muggeridge M, Cohen G, Eisenberg R . Herpes simplex virus infection can occur without involvement of the fibroblast growth factor receptor. J Virol. 1992; 66(2):824-30. PMC: 240782. DOI: 10.1128/JVI.66.2.824-830.1992. View

Johann S, Gibbons J, OHara B . GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a phosphate permease of Neurospora crassa and is expressed at high levels in the brain and thymus. J Virol. 1992; 66(3):1635-40. PMC: 240899. DOI: 10.1128/JVI.66.3.1635-1640.1992. View

Kari B, Gehrz R . A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope. J Virol. 1992; 66(3):1761-4. PMC: 240930. DOI: 10.1128/JVI.66.3.1761-1764.1992. View

BRETSCHER M . Circulating integrins: alpha 5 beta 1, alpha 6 beta 4 and Mac-1, but not alpha 3 beta 1, alpha 4 beta 1 or LFA-1. EMBO J. 1992; 11(2):405-10. PMC: 556468. DOI: 10.1002/j.1460-2075.1992.tb05068.x. View

10.

Chang K, Day C, Walker J, Hyypia T, Stanway G . The nucleotide sequences of wild-type coxsackievirus A9 strains imply that an RGD motif in VP1 is functionally significant. J Gen Virol. 1992; 73 ( Pt 3):621-6. DOI: 10.1099/0022-1317-73-3-621. View

11.

Ivanoff L, Dubay J, Morris J, Roberts S, Gutshall L, Sternberg E . V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity. Virology. 1992; 187(2):423-32. DOI: 10.1016/0042-6822(92)90444-t. View

12.

Grimaila R, Fuller B, Rennert P, Nelson M, Hammarskjold M, Potts B . Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization. J Virol. 1992; 66(4):1875-83. PMC: 288974. DOI: 10.1128/JVI.66.4.1875-1883.1992. View

13.

Breau W, Atwood W, Norkin L . Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J Virol. 1992; 66(4):2037-45. PMC: 288993. DOI: 10.1128/JVI.66.4.2037-2045.1992. View

14.

Hutchinson L, Browne H, Wargent V, Davis-Poynter N, Primorac S, Goldsmith K . A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J Virol. 1992; 66(4):2240-50. PMC: 289017. DOI: 10.1128/JVI.66.4.2240-2250.1992. View

15.

Selinka H, Zibert A, Wimmer E . A chimeric poliovirus/CD4 receptor confers susceptibility to poliovirus on mouse cells. J Virol. 1992; 66(4):2523-6. PMC: 289051. DOI: 10.1128/JVI.66.4.2523-2526.1992. View

16.

Sharpless N, OBRIEN W, Verdin E, Kufta C, Chen I, Dubois-Dalcq M . Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. J Virol. 1992; 66(4):2588-93. PMC: 289063. DOI: 10.1128/JVI.66.4.2588-2593.1992. View

17.

Li Q, Young L, Niedobitek G, Dawson C, Birkenbach M, Wang F . Epstein-Barr virus infection and replication in a human epithelial cell system. Nature. 1992; 356(6367):347-50. DOI: 10.1038/356347a0. View

18.

Batinic D, Robey F . The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J Biol Chem. 1992; 267(10):6664-71. View

19.

Bergelson J, Shepley M, Chan B, Hemler M, Finberg R . Identification of the integrin VLA-2 as a receptor for echovirus 1. Science. 1992; 255(5052):1718-20. DOI: 10.1126/science.1553561. View

20.

Janeway Jr C . T-cell development. Accessories or coreceptors?. Nature. 1988; 335(6187):208-10. DOI: 10.1038/335208a0. View